Zhengye Biotechnology Regains Nasdaq Bid Price Compliance; Shares Down

Zhengye Biotechnology (ZYBT) regained compliance with Nasdaq's $1 minimum bid price requirement. - Nasdaq confirmed the company's shares closed at $1 or higher for 10 consecutive business days from July 20 to August 4, 2026. - ZYBT shares down over 15% premarket

Zhengye Biotechnology (ZYBT) regained compliance with Nasdaq’s $1 minimum bid price requirement. – Nasdaq confirmed the company’s shares closed at $1 or higher for 10 consecutive business days from July 20 to August 4, 2026. – ZYBT shares down over 15% premarket

Leave a Reply

Your email address will not be published. Required fields are marked *